Unique ID issued by UMIN | UMIN000025751 |
---|---|
Receipt number | R000029610 |
Scientific Title | The longterm outcomes of macular neovascularization treated with intravitreal injections of anti-VGEF drugs |
Date of disclosure of the study information | 2017/02/01 |
Last modified on | 2022/02/03 00:24:43 |
The longterm outcomes of macular neovascularization treated with intravitreal injections of anti-VGEF drugs
AMD treated by anti-VEGF drugs
The longterm outcomes of macular neovascularization treated with intravitreal injections of anti-VGEF drugs
AMD treated by anti-VEGF drugs
Japan |
AMD
Ophthalmology |
Others
NO
Intravitreal injection of anti-VEGF drugs has been conducted as treatment for choroidal neovascularization by age-related macular degeneration, but it has not yet been completed. Study changes of choroidal neovascularization by vitreous administration of anti-VGEF drugs multifaceted.
Efficacy
Sex, age, visual acuity, visual field, refraction, corneal curvature radius, corneal thickness, ocular axial length, fundus observation,Optical coherence tomography, optical coherence tomography angiography, fundus photograph, fluorescence fundus angiography, slit lamp microscopy, duration of disease, current medical history, past history, family history, medication used, frequency of dosing
Observational
50 | years-old | <= |
Not applicable |
Male and Female
Patients who underwent intravitreal injection to Aflbercept for age-related macular degeneration from February 1, 2016 to August 31, 2017
nothing special
30
1st name | Keiko |
Middle name | |
Last name | Kataoka |
Nagoya University Hospital
Department of Ophthalmology
466-8560
65 Tsurumai-cho, Showa-ku, Nagoya
052-744-2275
kkeiko@med.nagoya-u.ac.jp
1st name | Keiko |
Middle name | |
Last name | Kataoka |
Nagoya University Hospital
Department of Ophthalmology
466-8560
65 Tsurumai-cho, Showa-ku, Nagoya
052-744-2275
kkeiko@med.nagoya-u.ac.jp
Nagoya University
Nagoya University
Self funding
Ethics Committee
65 Tsurumai-cho, Showa-ku, Nagoya
052-744-2973
ethics@med.nagoya-u.ac.jp
NO
2017 | Year | 02 | Month | 01 | Day |
Partially published
https://www.karger.com/Article/Abstract/487611
15
OCTA quantification revealed that CNV rebounded after repeat aflibercept injections despite shrinking in response to the first injection.
2020 | Year | 01 | Month | 22 | Day |
Main results already published
2016 | Year | 02 | Month | 01 | Day |
2017 | Year | 01 | Month | 06 | Day |
2017 | Year | 02 | Month | 01 | Day |
2020 | Year | 12 | Month | 31 | Day |
nothing special
2017 | Year | 01 | Month | 19 | Day |
2022 | Year | 02 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029610
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |